Regardless, I think we would be seeing another capital raise same time next year - hope they are already preparing for that (I can only play the devil's advocate so much).
Their opex is appropriate for their size and if anything I'd say it's quite decent given the push for growth, but not enough to drop that cash burn significantly and last over 12 months
We need to see quarterly revenues around that $ 1million mark to see positive EBITDA. GP margin is already quite high (82 to 85%), understand we should expect better margins in the coming quarters but there's a cap on that too - can't possibly go high enough to make a significant difference at the current revenue rate.
Fingers crossed they get a large order from one of the regions and/or Chinese markets regulatory approvals progress further - I suspect it will have to be the former, the latter might take a while.
ORrrrrr - get a large institutional placement.
- Forums
- ASX - By Stock
- OSX
- Ann: Activities Update Qtr Ending March 2023 and Appendix 4C
Ann: Activities Update Qtr Ending March 2023 and Appendix 4C, page-6
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.622M |
Open | High | Low | Value | Volume |
3.9¢ | 4.0¢ | 3.9¢ | $6.008K | 153.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 235631 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 86631 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 235631 | 0.037 |
3 | 218888 | 0.036 |
1 | 50000 | 0.034 |
1 | 18181 | 0.033 |
1 | 15625 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 86631 | 2 |
0.041 | 4142 | 1 |
0.042 | 610000 | 2 |
0.043 | 25000 | 1 |
0.045 | 55846 | 1 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
OSX (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online